# Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

> **NCT00003563** · PHASE3 · COMPLETED · sponsor: **Pharmacyclics LLC.** · enrollment: 430 (estimated)

## Conditions studied

- Metastatic Cancer

## Interventions

- **RADIATION:** WBRT
- **DRUG:** MGd

## Key facts

- **NCT ID:** NCT00003563
- **Lead sponsor:** Pharmacyclics LLC.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 2001-09
- **Final completion:** 2005-06
- **Target enrollment:** 430 (ESTIMATED)
- **Last updated:** 2013-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003563, "Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00003563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*